A phase II study of irinotecan as a third- or fourth-line treatment for advanced non-small cell lung cancer: NJLCG0703

✍ Scribed by Matsubara, Nobumichi; Maemondo, Makoto; Inoue, Akira; Ishimoto, Osamu; Watanabe, Kana; Sakakibara, Tomohiro; Fukuhara, Tatsuro; Morikawa, Naoto; Tanaka, Masashi; Sugawara, Shunichi; Nukiwa, Toshihiro

• Book ID: 121400339
• Publisher: Elsevier
• Year: 2013
• Tongue: English
• Weight: 321 KB
• Volume: 51
• Category: Article
• ISSN: 2212-5345
• DOI: 10.1016/j.resinv.2012.09.004